Exscientia EXAI Stock
4.66 USD
{{ price }}
-5.193476%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
587.09M USD
LOW - HIGH [24H]
4.61
-
4.87 USD
VOLUME [24H]
340.7K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.48 USD
Exscientia Price Chart
Exscientia EXAI Financial and Trading Overview
| Exscientia stock price | 4.66 USD |
| Previous Close | 6.94 USD |
| Open | 6.86 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 800 |
| Day's Range | 6.76 - 7.26 USD |
| 52 Week Range | 4.09 - 14.27 USD |
| Volume | 302.68K USD |
| Avg. Volume | 373.54K USD |
| Market Cap | 884.52M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.75 USD |
EXAI Valuation Measures
| Enterprise Value | 456.68M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.022472 |
| PEG Ratio (5 yr expected) | 0.07 |
| Price/Sales (ttm) | 34.00814 |
| Price/Book (mrq) | 1.9757173 |
| Enterprise Value/Revenue | 17.558 |
| Enterprise Value/EBITDA | -2.604 |
Trading Information
Exscientia Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -44.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.27 USD |
| 52 Week Low | 4.09 USD |
| 50-Day Moving Average | 6.14 USD |
| 200-Day Moving Average | 6.68 USD |
EXAI Share Statistics
| Avg. Volume (3 month) | 373.54K USD |
| Avg. Daily Volume (10-Days) | 336.04K USD |
| Shares Outstanding | 123.54M |
| Float | 104.42M |
| Short Ratio | 3.51 |
| % Held by Insiders | 27.87% |
| % Held by Institutions | 28.28% |
| Shares Short | 1.4M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 1.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -705.92% |
| Gross Margin | -38.90% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.36% |
| Return on Equity (ttm) | -28.15% |
Income Statement
| Revenue (ttm) | 26.01M USD |
| Revenue Per Share (ttm) | 0.21 USD |
| Quarterly Revenue Growth (yoy) | -17.39% |
| Gross Profit (ttm) | N/A |
| EBITDA | -175368000 USD |
| Net Income Avi to Common (ttm) | -140879008 USD |
| Diluted EPS (ttm) | -1.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 447.36M USD |
| Total Cash Per Share (mrq) | 3.62 USD |
| Total Debt (mrq) | 19.52M USD |
| Total Debt/Equity (mrq) | 4.36 USD |
| Current Ratio (mrq) | 7.031 |
| Book Value Per Share (mrq) | 3.624 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -88258000 USD |
| Levered Free Cash Flow (ttm) | -45293248 USD |
Profile of Exscientia
| Country | United States |
| State | N/A |
| City | Oxford |
| Address | The SchrOedinger Building |
| ZIP | OX4 4GE |
| Phone | 44 18 6581 8941 |
| Website | https://www.exscientia.ai |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 481 |
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. It also focuses on discovery and development of small molecule drug candidates. The company's platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. Exscientia plc was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Q&A For Exscientia Stock
What is a current EXAI stock price?
Exscientia EXAI stock price today per share is 4.66 USD.
How to purchase Exscientia stock?
You can buy EXAI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Exscientia?
The stock symbol or ticker of Exscientia is EXAI.
Which industry does the Exscientia company belong to?
The Exscientia industry is Biotechnology.
How many shares does Exscientia have in circulation?
The max supply of Exscientia shares is 126.12M.
What is Exscientia Price to Earnings Ratio (PE Ratio)?
Exscientia PE Ratio is now.
What was Exscientia earnings per share over the trailing 12 months (TTM)?
Exscientia EPS is -1.48 USD over the trailing 12 months.
Which sector does the Exscientia company belong to?
The Exscientia sector is Healthcare.
Exscientia EXAI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}